on November 24th, Bedo Finance learned that Neusoft Medical System Co., Ltd. (hereinafter referred to as "Neusoft Medical") had obtained the approval of China Securities Regulatory Commission to issue overseas listed foreign shares. This means that Neusoft Medical will issue shares overseas and will be listed on the Hong Kong Stock Exchange. At present, Neusoft Medical has not yet passed the hearing of the Hong Kong Stock Exchange. According to the information, Neusoft Medical submitted its listing application on the Hong Kong Stock Exchange on May 31, 221, and it has been nearly six months since then. According to the progress, Neusoft Medical will hold a hearing in the near future.
1. According to the previous prospectus, Neusoft Medical was established in 1998 as a global provider of medical imaging solutions and services, developing, manufacturing and distributing various advanced technical imaging, treatment and diagnosis products for medical service providers in China and around the world. It is understood that Neusoft Medical is behind Neusoft Group (6718.SH). In the shareholding structure before listing in Hong Kong, Neusoft Group holds 29.94%, Weizhi Global holds 26.52%, Neusoft Holdings holds 15.51%, Dalian Kangruidao holds 8.92%, and Tianjin Maiwang, an employee-owned platform, holds 5.%.
2. Among them, Liu Jiren, the chairman of Neusoft Medical, actually controls 4.47% of the shares of Neusoft Holdings through Dalian Kangrui Road. At the same time, Neusoft Holdings is also the largest shareholder of Neusoft Group, holding 12.97% of the shares of the latter. This represents that Liu Jiren is the ultimate actual controller of the company.
3. According to the data of Jost Sullivan, Neusoft Medical is the largest manufacturer of CT systems in China in terms of the total number of installed systems and total revenue in 219. According to the sales volume in 219, Neusoft Medical is also the largest exporter of CT systems in China.
4. According to the prospectus submitted by Neusoft Medical in science and technology innovation board, by the end of 219, Neusoft Medical had 2,573 sets of CT equipment in the China market, accounting for 1.4% of the China market, ranking first among domestic brands, second only to GE, Siemens and Philips.
5. In 218, 219 and 22, Neusoft Medical's operating income was 1.912 billion yuan, 1.98 billion yuan and 2.459 billion yuan respectively, all of which maintained a growth trend; The net profit was 169 million yuan, 82.4 million yuan and 92.758 million yuan respectively, of which 219 and 22 were lower than 218.
6. As of December 31, 22, Neusoft Medical held 55 million yuan in cash and cash equivalents. In contrast, in the same period of 219, it was 776 million yuan, while as of December 31, 218, it was 1.157 billion yuan, decreasing year by year. In 218, 219 and 22, Neusoft Medical's R&D expenditure was 17 million yuan, 181 million yuan and 222 million yuan respectively, accounting for 8.91%, 9.47% and 9.2% of the total revenue respectively; The sales and distribution expenses were 335 million yuan, 333 million yuan and 361 million yuan respectively, about twice as much as the R&D expenses in the same period.
7. By December 31st, 22, Neusoft Medical's global R&D team had employed 865 R&D professionals. According to the prospectus, its R&D team members have extensive professional knowledge in the design and manufacture of medical imaging devices, software engineering, AI, cloud computing and other technologies.
8. According to the data of Wisdom Bud, Neusoft Medical has applied for 283 patents, the earliest patent application was in 22, and the patent growth rate in the past three years was 48.49%. Among them, there are 1241 non-appearance patents, accounting for 96.73%, including 115 invention patents and 91 utility models.
9. In terms of technical field layout, Neusoft Medical's patents focus on detector, CT scanning, image reconstruction, medical equipment, scanning bed and other technical fields. Judging from the R&D team, Neusoft Medical has 839 inventors, among which Lou Shanshan is the inventor with the largest number of inventions.
1. It is worth mentioning that Neusoft Medical once had a number of patent transfer information. It is understood that the transfer of core patents may lead to a decline in the performance of the original business. However, Wisdom Bud data shows that Neusoft Medical * * * has 25 patent transfer records, most of which are affiliated companies, and some of them are related to Philips (China) Investment Co., Ltd.